Relating to fentanyl; declaring an emergency.
SB 507 creates a separate set of Oregon criminal statutes specifically for fentanyl and fentanyl derivatives, rather than treating fentanyl only through the general controlled-substance provisions. It makes knowing possession, delivery, and manufacture of fentanyl unlawful under new sections, and sets offense levels based on quantity and circumstances. Possession is generally a drug enforcement misdemeanor, but becomes a Class A misdemeanor at one gram or five user units, and a Class C felony for commercial drug offenses or substantial quantities. Delivery is a Class B felony, elevated to a Class A felony if the delivery is to a person under 18 or occurs within 1,000 feet of a school. Manufacture is a Class B felony, also elevated to a Class A felony near schools.
The bill also amends Oregon’s sentencing and diversion laws to treat fentanyl more severely in several contexts. It adds fentanyl to the list of offenses subject to mandatory minimum incarceration for delivery to minors, and it bars optional probation or downward departures for repeat fentanyl manufacture or delivery convictions beginning July 1, 2033. It updates sentencing-guideline provisions defining commercial drug offenses and substantial quantities to include fentanyl-specific thresholds, and it adds fentanyl possession to the list of offenses eligible for Oregon’s drug-enforcement misdemeanor probation agreement process. The bill also revises the state’s overdose immunity law so that people who seek emergency help for an overdose are protected from arrest, prosecution, or civil penalties for fentanyl possession and related listed offenses.
SB 507 further aligns several existing statutes with the new fentanyl-specific framework. It amends provisions governing probation agreements, community corrections supervision, and sentencing consequences so fentanyl offenses are treated similarly to other serious drug offenses such as heroin, cocaine, and methamphetamine, while preserving treatment-oriented options for low-level possession cases. The bill also makes conforming changes to Oregon laws on school-zone drug offenses, repeat-offender sentencing restrictions, and the definitions used by county supervision authorities. It declares an emergency, so it would take effect immediately upon passage.
The overall sentiment reflected by the bill text is punitive and public-safety oriented, with a strong focus on fentanyl as a distinct and especially dangerous drug. Although no committee transcript or vote record is provided, the structure of the measure suggests an intent to increase penalties, create clearer fentanyl-specific offenses, and target distribution near minors and schools. At the same time, the bill retains some treatment and diversion mechanisms for simple possession, indicating a mixed enforcement-and-treatment approach rather than a purely punitive one.
The main points of contention likely concern the balance between tougher criminal penalties and Oregon’s recent drug-policy reforms. Supporters would likely emphasize fentanyl’s lethality, the need for stronger penalties for delivery to minors and school-zone activity, and the value of clearer statutory treatment of fentanyl offenses. Critics would likely focus on the expansion of felony exposure, mandatory minimums, and limits on probation or downward departures for repeat offenses, as well as whether harsher penalties will improve public health outcomes or disproportionately affect people with substance use disorders.
The bill would create new fentanyl-specific criminal statutes and conforming amendments across Oregon’s controlled-substance, sentencing, probation, community corrections, and overdose-immunity laws. It would increase penalties for fentanyl possession, delivery, manufacture, school-zone offenses, and delivery to minors, while also adding fentanyl to existing diversion and treatment-related provisions for low-level possession. It would affect defendants, prosecutors, courts, county community corrections agencies, and people seeking overdose assistance, and it would amend multiple ORS sections and provisions of the 2024 drug-law overhaul.
The measure appears generally tough-on-drugs and public-safety focused, with fentanyl treated as a distinct and especially serious threat. The bill’s design suggests support for stronger penalties and clearer enforcement tools, while still preserving some treatment-oriented options for possession and overdose situations. No committee testimony or recorded votes were provided, so the broader political reaction cannot be directly measured from the supplied materials.
Likely points of contention are the bill’s increased felony penalties, school-zone enhancements, mandatory minimum for delivery to minors, and the restriction on probation or downward departures for repeat fentanyl manufacture or delivery. Supporters would likely argue these provisions are necessary to address fentanyl overdose deaths and trafficking, especially around youth and schools. Opponents would likely argue that the bill relies too heavily on incarceration, may duplicate or complicate existing drug statutes, and could undermine treatment-centered approaches for substance use disorder.